DE69330238D1 - Verfahren zur Herstellung des Ectoproteins des Hepatitis-C-Virus - Google Patents

Verfahren zur Herstellung des Ectoproteins des Hepatitis-C-Virus

Info

Publication number
DE69330238D1
DE69330238D1 DE69330238T DE69330238T DE69330238D1 DE 69330238 D1 DE69330238 D1 DE 69330238D1 DE 69330238 T DE69330238 T DE 69330238T DE 69330238 T DE69330238 T DE 69330238T DE 69330238 D1 DE69330238 D1 DE 69330238D1
Authority
DE
Germany
Prior art keywords
ectoprotein
hepatitis
virus
production
virus ectoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69330238T
Other languages
English (en)
Other versions
DE69330238T2 (de
DE69330238T3 (de
Inventor
Tatsuo Miyamura
Izumu Saito
Yoshiharu Matsuura
Yoshikazu Honda
Makoto Seki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institutes of Health NIH
Original Assignee
National Institutes of Health NIH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15541558&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69330238(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by National Institutes of Health NIH filed Critical National Institutes of Health NIH
Publication of DE69330238D1 publication Critical patent/DE69330238D1/de
Publication of DE69330238T2 publication Critical patent/DE69330238T2/de
Application granted granted Critical
Publication of DE69330238T3 publication Critical patent/DE69330238T3/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/36011Togaviridae
    • C12N2770/36111Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE69330238T 1992-06-11 1993-06-09 Verfahren zur Herstellung des Ectoproteins des Hepatitis-C-Virus Expired - Fee Related DE69330238T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4152487A JPH05344899A (ja) 1992-06-11 1992-06-11 C型肝炎ウイルス外被タンパク質の産生法
JP15248792 1992-06-11

Publications (3)

Publication Number Publication Date
DE69330238D1 true DE69330238D1 (de) 2001-06-28
DE69330238T2 DE69330238T2 (de) 2001-11-08
DE69330238T3 DE69330238T3 (de) 2008-07-17

Family

ID=15541558

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69330238T Expired - Fee Related DE69330238T3 (de) 1992-06-11 1993-06-09 Verfahren zur Herstellung des Ectoproteins des Hepatitis-C-Virus

Country Status (5)

Country Link
US (3) US5789544A (de)
EP (1) EP0585549B2 (de)
JP (1) JPH05344899A (de)
CA (1) CA2098253C (de)
DE (1) DE69330238T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514539A (en) * 1993-06-29 1996-05-07 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
US5610009A (en) * 1994-01-28 1997-03-11 Abbott Laboratories Mammalian expression systems for hepatitis C virus envelope genes
US20040185061A1 (en) * 1994-07-29 2004-09-23 Innogenetics N.V. Redox reversible HCV proteins with native-like conformation
ES2174957T5 (es) * 1994-07-29 2006-12-16 Innogenetics N.V. Proteinas purificadas de envoltura de virus de la hepatitis c para uso diagnostico y terapeutico.
US6183744B1 (en) * 1997-03-24 2001-02-06 Immunomedics, Inc. Immunotherapy of B-cell malignancies using anti-CD22 antibodies
US6306393B1 (en) * 1997-03-24 2001-10-23 Immunomedics, Inc. Immunotherapy of B-cell malignancies using anti-CD22 antibodies
CN1086421C (zh) * 1997-10-14 2002-06-19 复旦大学 丙型肝炎病毒复合多价疫苗基因的合成与克隆
EP0947525A1 (de) 1998-03-27 1999-10-06 Innogenetics N.V. Epitope in der viralen Hüllproteine und spezifische Antikörper gegen diese Epitope: Verwendung für die detektion von viralantigene im empfängergewebe
US7108855B2 (en) * 1998-06-24 2006-09-19 Innogenetics N.V. Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
US6969569B2 (en) * 1999-04-16 2005-11-29 Applied Materials, Inc. Method of extending the stability of a photoresist during direct writing of an image
US7101561B2 (en) 2000-12-01 2006-09-05 Innogenetics N.V. Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
JP4912153B2 (ja) 2003-12-01 2012-04-11 イミューノメディクス、インコーポレイテッド タンパク質とキレート剤とのコンジュゲートを調製するための改良された方法
CA2571710A1 (en) * 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
EP2201023A2 (de) * 2007-09-14 2010-06-30 GENimmune N.V. Affinitäts-tag

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2656995B2 (ja) * 1989-03-17 1997-09-24 カイロン コーポレイション Nanbvの診断用薬
JP3050395B2 (ja) * 1990-06-12 2000-06-12 国立感染症研究所長 C型肝炎ウイルス抗原ポリペプチド、その産生方法および抗体の検出方法
NZ238681A (en) * 1990-06-25 1992-03-26 Univ Osaka Res Found Non-a, non-b hepatitis virus particles and their production
JP3114731B2 (ja) * 1990-08-14 2000-12-04 国立感染症研究所長 C型肝炎ウイルス抗体検出用ペプチド抗原及びその使用方法
WO1992003161A1 (en) * 1990-08-27 1992-03-05 The United States Of America, Represented By The Secretary, United States Department Of Commerce Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection
JP3158177B2 (ja) * 1991-10-08 2001-04-23 国立感染症研究所長 C型肝炎診断薬

Also Published As

Publication number Publication date
CA2098253C (en) 2007-02-27
CA2098253A1 (en) 1993-12-12
DE69330238T2 (de) 2001-11-08
EP0585549A2 (de) 1994-03-09
US5830691A (en) 1998-11-03
EP0585549A3 (en) 1994-07-06
US6063904A (en) 2000-05-16
US5789544A (en) 1998-08-04
EP0585549B1 (de) 2001-05-23
DE69330238T3 (de) 2008-07-17
JPH05344899A (ja) 1993-12-27
EP0585549B2 (de) 2008-01-09

Similar Documents

Publication Publication Date Title
DE69330238T2 (de) Verfahren zur Herstellung des Ectoproteins des Hepatitis-C-Virus
DE69306016D1 (de) Verfahren zur Herstellung von Acrolein
DE69314142T2 (de) Verfahren zur Herstellung von Keramikteilen
DE69310232T2 (de) Verfahren zur Herstellung von Organomonochlorsilan
DE59303220D1 (de) Verfahren zur Herstellung von 1-Fluorcyclopropyl-methyl-keton
DE69314899T2 (de) Verfahren zur Herstellung von Polyaminoborazinen
DE59302489D1 (de) Verfahren zur Herstellung von Chlor-Fluor-Butenen
DE69315297D1 (de) Verfahren zur Herstellung von Omega-Alkenylchlorsilanen
DE69325079T2 (de) Verfahren zur Herstellung von Triorganochlorsilane
DE69303057T2 (de) Verfahren zur Herstellung von 3-Cyano-6-hydroxypyridin
DE69315317D1 (de) Verfahren zur Herstellung von beta-Cyanoalkylsilanen
DE69304224D1 (de) Verfahren zur Herstellung von P-Aminophenolen
DE69321661D1 (de) Verfahren zur Herstellung von Triorganomonohalogensilan
DE69318765T2 (de) Verfahren zur Herstellung von Hydridoorganooxysilanen
DE69116499T2 (de) Verfahren zur Herstellung von Alpha-Hydroxyketonen
DE59206474D1 (de) Verfahren zur Herstellung von Keramikteilen
DE69305279T2 (de) Verfahren zur Herstellung von Dimethyltetralin
DE69308193T2 (de) Verfahren zur Herstellung von Alpha-L-Aspartyl-L-Phenylalanin
DE59306959D1 (de) Verfahren zur Herstellung von Difluor- und Chlorfluorbenzodioxolen
DE69322893D1 (de) Verfahren zur Herstellung von Epsilon-poly-L-Lysin
DE59304663D1 (de) Verfahren zur Herstellung von 4-Hydroxymethyltetrahydropyran
DE69303656D1 (de) Verfahren zur Herstellung von 2-Oxytetrahydrofurane
DE69315979D1 (de) Verfahren zur Herstellung von 1-Phenoxy-2-aminopropan
DE59310105D1 (de) Verfahren zur Herstellung von 2-Amino-5-methyl-pyridin
DE59308865D1 (de) Verfahren zur Herstellung von Chlorphenylphosphanen

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8339 Ceased/non-payment of the annual fee